Tefron Ltd.
TFRFF
$6.46
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 277.34M | 293.86M | 292.26M | 277.11M | 264.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 277.34M | 293.86M | 292.26M | 277.11M | 264.08M |
| Cost of Revenue | 215.94M | 227.38M | 225.14M | 213.93M | 204.04M |
| Gross Profit | 61.40M | 66.48M | 67.12M | 63.18M | 60.04M |
| SG&A Expenses | 34.87M | 35.65M | 34.80M | 32.41M | 31.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 639.00K | 639.00K | 668.00K | 668.00K | 668.00K |
| Total Operating Expenses | 258.37M | 270.76M | 267.55M | 253.49M | 242.03M |
| Operating Income | 18.97M | 23.11M | 24.71M | 23.62M | 22.05M |
| Income Before Tax | 15.88M | 19.56M | 20.75M | 19.49M | 17.88M |
| Income Tax Expenses | 3.22M | 4.45M | 4.81M | 4.58M | 4.51M |
| Earnings from Continuing Operations | 12.66 | 15.11 | 15.94 | 14.91 | 13.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.66M | 15.11M | 15.94M | 14.91M | 13.38M |
| EBIT | 18.97M | 23.11M | 24.71M | 23.62M | 22.05M |
| EBITDA | 26.30M | 30.44M | 32.11M | 30.78M | 28.72M |
| EPS Basic | 1.00 | 1.20 | 1.28 | 1.20 | 1.09 |
| Normalized Basic EPS | 0.78 | 0.97 | 1.04 | 0.98 | 0.91 |
| EPS Diluted | 0.93 | 1.12 | 1.19 | 1.13 | 1.03 |
| Normalized Diluted EPS | 0.73 | 0.91 | 0.97 | 0.92 | 0.86 |
| Average Basic Shares Outstanding | 50.54M | 50.48M | 49.83M | 49.72M | 49.25M |
| Average Diluted Shares Outstanding | 53.55M | 53.35M | 53.74M | 52.93M | 52.22M |
| Dividend Per Share | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 |
| Payout Ratio | 15.76% | 13.20% | 12.52% | 13.38% | -- |